Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 71 Colorectal Neoplasms 34 Rectal Neoplasms 33 Esophageal Neoplasms 25 Carcinoma, Non-Small-Cell Lung 24 Esophageal Squamous Cell Carcinoma 23 Pancreatic Neoplasms 16 Stomach Neoplasms 15 Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Adenocarcinoma Of Esophagus 14 Sarcoma 11 Ovarian Neoplasms 11 Lung Neoplasms 11 Colonic Neoplasms 11 Carcinoma, Hepatocellular 11 Prostatic Neoplasms 10 Head and Neck Neoplasms 10 Neoplasm Metastasis 9 Urinary Bladder Neoplasms 8 Uterine Cervical Neoplasms 7 Recurrence 6 Osteosarcoma 6 Multiple Myeloma 5 Fallopian Tube Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Breast Carcinoma In Situ 5 Peritoneal Neoplasms 4 Nasopharyngeal Carcinoma 4 Locally Advanced Rectal Cancer 4

Interventions

Gemcitabine 39 Cisplatin 24 Oxaliplatin 21 Capecitabine 20 Fluorouracil 11 Leucovorin 9 Irinotecan 9 130-nm albumin-bound paclitaxel 8 durvalumab 6 Taxes 5 Radiotherapy 5 Platinum 4 Immunohistochemistry 4 Erlotinib Hydrochloride 4 Docetaxel 4 Carboplatin 4 Bevacizumab 4 Albumin-Bound Paclitaxel 4 1,2-diaminocyclohexaneplatinum II citrate 4 trifluridine tipiracil drug combination 3 Trastuzumab 3 Sorafenib 3 Observation 3 Epirubicin 3 Drug Therapy 3 tremelimumab 2 toripalimab 2 regorafenib 2 pembrolizumab 2 anlotinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gallbladder Neoplasms × Neoadjuvant Therapy × Clear all

NCT06712420 2025-04-16

NEOGB

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 3 Recruiting

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡